Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ENvue Medical, Inc. (FEED : NSDQ)

• Company Description    ENvue Medical Holdings Corp. is an electromagnetic navigation technology, providing real-time guidance for enteral feeding tube placement across critical care, step-down units and general medical-surgical floors in hospitals. ENvue Medical Holdings Corp., formerly known as NanoVibronix Inc., is based in ELMSFORD, N.Y. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $4.03 Daily Weekly Monthly 20 Day Moving Average: 138,193 shares Shares Outstanding: 0.92 (millions) Market Capitalization: $3.72 (millions) Beta: 1.38 52 Week High: $128.40 52 Week Low: $3.48 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -18.91% -18.55% 12 Week -58.04% -58.93% Year To Date -85.47% -87.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 969 PRUITT AVE - TYLER,TX 77569 USA ph: 914-233-3004 fax: 914-376-6111 brett@haydenir.com http://www.envuemed.com

• General Corporate Information    Officers Doron Besser - Chief Executive Officer and Director David Johnson - Chairman of the Board Zeev Rotstein - Director Allison Burgett - Director Nino Pionati - Director Peer Information ENvue Medical, Inc. (ABMD) ENvue Medical, Inc. (DMDS) ENvue Medical, Inc. (CPWY.) ENvue Medical, Inc. (EQUR) ENvue Medical, Inc. (ECIA) ENvue Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 63008J876 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 0.92 Most Recent Split Date: 9.00 (0.08:1) Beta: 1.38 Market Capitalization: $3.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.09 Price/Cash Flow: - Price / Sales: 1.93 EPS Growth vs. Year Ago Period: -92.24% vs. Previous Quarter: 71.22% Sales Growth vs. Year Ago Period: -51.62% vs. Previous Quarter: -63.40% ROE 06/30/26 - -60.73 03/31/26 - -54.25 12/31/25 - -49.46 ROA 06/30/26 - -48.48 03/31/26 - -43.10 12/31/25 - -39.37 Current Ratio 06/30/26 - 0.66 03/31/26 - 0.90 12/31/25 - 1.09 Quick Ratio 06/30/26 - 0.31 03/31/26 - 0.57 12/31/25 - 0.74 Operating Margin 06/30/26 - -1,093.61 03/31/26 - -923.20 12/31/25 - -736.70 Net Margin 06/30/26 - -1,093.61 03/31/26 - -923.20 12/31/25 - -736.70 Pre-Tax Margin 06/30/26 - -1,111.94 03/31/26 - -936.45 12/31/25 - -724.32 Book Value 06/30/26 - 45.06 03/31/26 - 103.85 12/31/25 - 365.43 Inventory Turnover 06/30/26 - 1.03 03/31/26 - 1.08 12/31/25 - 1.09 Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©